common.study.topics.clinical

Alcohol, Cannabis, and Driving Substudy III

common.study.values.description

Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition: Substudy III

The overarching goal of this study is to characterize the effects of ethanol and cannabinoids on simulated driving and related cognition.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

Pharmaceutical medication involved common.study.methods.has-drugs-yes
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Drug - Active Dronabinol

10 mg capsule of Dronabinol will be administered orally.

Drug - Placebo

Control: no alcohol, administered for ~80 minutes.

Drug - Placebo

Control: Placebo pill (no active cannabinoids) administered orally.

Drug - Active Ethanol

Target BrAC of 0.04% reached over 20 minutes and then clamped to maintain this dose for an additional 60 minutes. This dose is equivalent to consuming approximately 2 drinks over 1 hour. Administered over a total of 80 minutes.

participant.views.study.view.additional

participant.views.study.view.scientific-title

Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition: Substudy III

common.study.values.clinical-trial-id

NCT02710331

participant.views.study.view.id

ZdPJ6a